Skip to main content

Table 2 Cost effectiveness of HPV vaccination in Estonia, model estimates

From: The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia

 

Discounted total

Incremental

 

Costs/person (€)*

QALY/person (year)**

Costs/person (€)*

QALY/person (year)**

Costs/QALYs (€/year)***

No vaccination

126.29

27.09184

--

--

--

Routine vaccination

152.79

27.09726

26.5

0.00542

4889

  1. *Costs rounded to 0.01; **QALYs rounded to 0.00001; ***Costs/QALYs rounded to 1.